1. AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. Issue 7 (24th January 2023) Authors: Todisco, Elisabetta; Papayannidis, Cristina; Fracchiolla, Nicola; Petracci, Elisabetta; Zingaretti, Chiara; Vetro, Calogero; Martelli, Maria Paola; Zappasodi, Patrizia; Di Renzo, Nicola; Gallo, Susanna; Audisio, Ernesta; Griguolo, Davide; Cerchione, Claudio; Selleri, Carmine; Mattei, Daniele; Ber... Journal: Cancer Issue: Volume 129:Issue 7(2023) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BCR:ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC". (8th October 2022) Authors: Di Giusto, Sara; Toffoletti, Eleonora; Bonifacio, Massimiliano; Binotto, Gianni; Miggiano, Maria Cristina; Calistri, Elisabetta; Stulle, Manuela; Ermacora, Anna; Stella, Rossella; Scaffidi, Luigi; D'Amore, Fabio; Scotton, Giorgia; Griguolo, Davide; De Matteis, Giovanna; Bertorelle, Roberta; Kramp... Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 3180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803]. (April 2022) Authors: De Bellis, Eleonora; Imbergamo, Silvia; Candoni, Anna; Liço, Albana; Tanasi, Ilaria; Mauro, Endri; Mosna, Federico; Leoncin, Matteo; Stulle, Manuela; Griguolo, Davide; Pravato, Stefano; Trentin, Livio; Lazzarotto, Davide; Di Bona, Eros; Sancetta, Rosaria; Lucchini, Elisa; Poiani, Monica; Palmieri... Journal: Leukemia research Issue: Volume 115(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis. Issue 6 (20th December 2019) Authors: Palandri, Francesca; Breccia, Massimo; Bonifacio, Massimiliano; Polverelli, Nicola; Elli, Elena M.; Benevolo, Giulia; Tiribelli, Mario; Abruzzese, Elisabetta; Iurlo, Alessandra; Heidel, Florian H.; Bergamaschi, Micaela; Tieghi, Alessia; Crugnola, Monica; Cavazzini, Francesco; Binotto, Gianni; Isi... Journal: Cancer Issue: Volume 126:Issue 6(2020) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax. Issue 4 (9th February 2023) Authors: Candoni, Anna; Lazzarotto, Davide; Papayannidis, Cristina; Piccini, Matteo; Nadali, Giampaolo; Dargenio, Michelina; Riva, Marta; Fracchiolla, Nicola; Mellillo, Lorella; Dragonetti, Giulia; Del Principe, Maria Ilaria; Cattaneo, Chiara; Stulle, Manuela; Pasciolla, Crescenza; De Marchi, Roberta; Del... Journal: American journal of hematology Issue: Volume 98:Issue 4(2023) Page Start: E80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real‐world data. Issue 3 (20th April 2020) Authors: Palandri, Francesca; Breccia, Massimo; Tiribelli, Mario; Bonifacio, Massimiliano; Benevolo, Giulia; Iurlo, Alessandra; Elli, Elena M.; Binotto, Gianni; Tieghi, Alessia; Polverelli, Nicola; Martino, Bruno; Abruzzese, Elisabetta; Bergamaschi, Micaela; Heidel, Florian H.; Cavazzini, Francesco; Crugn... Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy. (November 2018) Authors: Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, Gianni; Miggiano, Maria Cristina; Danini, Marco; Minotto, Claudia; Griguolo, Davide; Marin, Luciana; Frison, Luca; D'Amore, Fabio; Basso, Marco; Sartori, Roberto; Tinelli, Martina; Stulle, Manuela; Fortuna, Stefania; Bonalumi, Angela; Bertoldero,... Journal: Leukemia research Issue: Volume 74(2018) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience. (March 2022) Authors: De Bellis, Eleonora; Imbergamo, Silvia; Candoni, Anna; Liço, Albana; Tanasi, Ilaria; Mauro, Endri; Mosna, Federico; Leoncin, Matteo; Stulle, Manuela; Griguolo, Davide; Pravato, Stefano; Trentin, Livio; Lazzarotto, Davide; Di Bona, Eros; Bassan, Renato; Lucchini, Elisa; Poiani, Monica; Palmieri, C... Journal: Leukemia research Issue: Volume 114(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗